Trial Profile
A phase 1 trial for an ADC for hematologic malignancies
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 07 Aug 2015
Price :
$35
*
At a glance
- Drugs Immunoconjugates (Primary)
- Indications Haematological malignancies
- Focus Adverse reactions
- 07 Aug 2015 New trial record